Institut für Virologie

Ulrike Protzer
- Lehrstuhl für Virologie
Person
19932026
Michael Roggendorf
- Institut für Virologie
Person
19752024

Engineered ACE2-IgG fusion proteins as broad-spectrum receptor-traps that neutralize coronaviruses
Protzer, U. (Sprecherschaft), Buchner, J. (CoPI) & Svilenov, H. (CoPI)
1/07/24 → 30/06/26
Projekt: Forschung

306 Artikel
30 Übersichtsartikel
16 Brief
13 Kommentar/Debatte
Mehr

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial
Wu, X., Quan, D., Li, W., Wisskirchen, K., Wu, W., Zhou, Y., Liu, Y. P., Wan, X., Wang, X., Zhang, X., Yang, L., Zheng, M., Zhang, K., Protzer, U., Du, S. & Qu, X., 1 Jan. 2026, in: Gut. 75, 1, S. 147-160 14 S.
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Open Access
9 Zitate (Scopus)
Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis B
Battistella, S., Protzer, U. & Forns, X., Apr. 2026, in: JHEP Reports. 8, 4, 101741.
Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte

Open Access
Erratum: Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS (Cancer Cell (2017) 31(6) (771–789.e6), (S1535610817302027), (10.1016/j.ccell.2017.05.006))
Yuan, D., Huang, S., Berger, E., Liu, L., Gross, N., Heinzmann, F., Ringelhan, M., Connor, T. O., Stadler, M., Meister, M., Weber, J., Öllinger, R., Simonavicius, N., Reisinger, F., Hartmann, D., Meyer, R., Reich, M., Seehawer, M., Leone, V. & Höchst, B. &24 mehr, Wohlleber, D., Jörs, S., Prinz, M., Spalding, D., Protzer, U., Luedde, T., Terracciano, L., Matter, M., Longerich, T., Knolle, P., Ried, T., Keitel, V., Geisler, F., Unger, K., Cinnamon, E., Pikarsky, E., Hüser, N., Davis, R. J., Tschaharganeh, D. F., Rad, R., Weber, A., Zender, L., Haller, D. & Heikenwalder, M., 9 Feb. 2026, in: Cancer Cell. 44, 2, S. 444-447 4 S.
Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte

Institut für Virologie

Kooperationen und Spitzenforschungsbereiche der letzten fünf Jahre

Details ergründen

Ulrike Protzer

Michael Roggendorf

Engineered ACE2-IgG fusion proteins as broad-spectrum receptor-traps that neutralize coronaviruses

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial

Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis B

Erratum: Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS (Cancer Cell (2017) 31(6) (771–789.e6), (S1535610817302027), (10.1016/j.ccell.2017.05.006))

Institut für Virologie

Kooperationen und Spitzenforschungsbereiche der letzten fünf Jahre

Profile

Ulrike Protzer

Michael Roggendorf

Projekte

Engineered ACE2-IgG fusion proteins as broad-spectrum receptor-traps that neutralize coronaviruses

Publikationen

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial

Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis B

Erratum: Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS (Cancer Cell (2017) 31(6) (771–789.e6), (S1535610817302027), (10.1016/j.ccell.2017.05.006))